Scarica l'app Stockscreener
9.45
0.43%
0.04
Poseida Therapeutics Inc Azioni (PSTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
12.59%
28.14
|
25.00 | 9.352 | 20.01 | 10.34 |
Operating Expenses
|
3.57%
52.72
|
50.90 | 45.57 | 47.87 | 49.86 |
| Interest Income/Expense |
0.62%
2.253
|
2.267 | 2.236 | 2.141 | 2.028 |
| Benefits Costs and Expenses |
4.12%
52.42
|
50.34 | 41.02 | - | 49.19 |
| Costs And Expenses |
4.12%
52.42
|
50.34 | 41.02 | 47.87 | 49.19 |
| Depreciation and Amortization |
4.03%
1.38
|
1.438 | 1.40 | 1.40 | 1.324 |
| Operating Income/Loss |
5.14%
-24.58
|
-25.91 | -36.22 | -27.86 | -39.52 |
| Income/Loss From Continuing Operations Before Tax |
4.24%
-24.27
|
-25.35 | -31.67 | -27.46 | -38.85 |
| Income/Loss From Continuing Operations After Tax |
4.24%
-24.27
|
-25.35 | -31.78 | -27.46 | -38.85 |
|
Net Income/Loss
|
4.24%
-24.27
|
-25.35 | -31.78 | -27.46 | -38.85 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,054%
96.02
|
1.8632 | 91.90 | 86.79 | 86.27 |
| Diluted Average Shares |
5,054%
96.02
|
1.8632 | 91.90 | 86.79 | 86.27 |
| Basic Earnings Per Share |
3.85%
-0.25
|
-0.26 | -0.35 | -0.32 | -0.45 |
| Diluted Earnings Per Share |
3.85%
-0.25
|
-0.26 | -0.35 | -0.32 | -0.45 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):